These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9410899)

  • 21. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
    Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
    Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respective roles of TNF-alpha and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice.
    Benihoud K; Esselin S; Descamps D; Jullienne B; Salone B; Bobé P; Bonardelle D; Connault E; Opolon P; Saggio I; Perricaudet M
    Gene Ther; 2007 Mar; 14(6):533-44. PubMed ID: 17109009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus.
    Stein CS; Pemberton JL; van Rooijen N; Davidson BL
    Gene Ther; 1998 Apr; 5(4):431-9. PubMed ID: 9614566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of adenovirus mediated gene transfer to mouse testis in vivo on spermatogenesis and next generation.
    Kojima Y; Sasaki S; Umemoto Y; Hashimoto Y; Hayashi Y; Kohri K
    J Urol; 2003 Nov; 170(5):2109-14. PubMed ID: 14532865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro.
    Diao J; Smythe JA; Smyth C; Rowe PB; Alexander IE
    Gene Ther; 1999 May; 6(5):845-53. PubMed ID: 10505110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.
    Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB
    Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
    J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
    J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.
    Yang Y; Greenough K; Wilson JM
    Gene Ther; 1996 May; 3(5):412-20. PubMed ID: 9156802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.
    Lasarte JJ; Corrales FJ; Casares N; López-Díaz de Cerio A; Qian C; Xie X; Borrás-Cuesta F; Prieto J
    J Immunol; 1999 May; 162(9):5270-7. PubMed ID: 10228002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
    Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
    Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term retinal transgene expression with FIV versus adenoviral vectors.
    Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
    Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy.
    Schröder G; Risch K; Nizze H; Kolls J; Reinke P; Brock J; Lehmann M; Volk HD; Ritter T
    Transplantation; 2000 Jul; 70(1):191-8. PubMed ID: 10919599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients.
    Molinier-Frenkel V; Le Boulaire C; Le Gal FA; Gahéry-Segard H; Tursz T; Guillet JG; Farace F
    Hum Gene Ther; 2000 Sep; 11(13):1911-20. PubMed ID: 10986563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.
    Sharpe S; Fooks A; Lee J; Hayes K; Clegg C; Cranage M
    Virology; 2002 Feb; 293(2):210-6. PubMed ID: 11886240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.